FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to biotechnology. What is presented is the strain Bifidobacterium longum NCIMB 41676 possessing the immunomodulatory action. The above strain is applicable as an anti-infectious probiotic strain. What is also presented is a probiotic formulation containing the above strain and a carrier for oral administration. What is also presented is using the formulation as a cognitive function enhancer for preventing the central nervous system disorders, such as Alzheimer disease, schizophrenia and/or mild cognitive disorders. Alternatively, what is used is the formulation for preventing an inflammation related to obesity, for preventing metabolic disorders related to obesity.
EFFECT: group of inventions provides increasing anti-inflammatory cytokine IL-10 and decreasing proinflammatory cytokines and lipopolysaccharide induced HfkB activity.
37 cl, 16 dwg, 6 tbl, 8 ex
